Methylphenidate for Epilepsy-related Cognitive Deficits
Phase 4
226
about 4.1 years
18+
4 sites in FL, MA, NY +1
What this study is about
This trial is testing if methylphenidate, a stimulant medication used to treat ADHD, can help with attention and memory problems in adults who have epilepsy. Participants will be randomly assigned to take either methylphenidate or a placebo (sugar pill) and their cognitive function will be tested at different points during it.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Placebo
- 2.Take Methylphenidate
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
methylphenidate (CNS stimulant; blocks reuptake of dopamine and norepinephrine)
oral (Disintegrating Oral Tablet)
Secondary: Change in Overall Quality of Life, Following Placebo vs. Methylphenidate, Change in Overall Subjective Quality of Life, Post-Open-Label
Neurology